» Articles » PMID: 27244766

Use of Recombinant Luteinizing Hormone for Controlled Ovarian Hyperstimulation in Infertile Patients

Overview
Date 2016 Jun 1
PMID 27244766
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Controlled ovarian stimulation has become an integral part of a high complexity infertility treatment. Treatment options with recombinant gonadotrophins add more to knowledge on folliculogenesis and ovarian steroidogenesis. Therefore, a literature search was conducted in the following data bases: Medline, Scielo and PubMed. The descriptors/ key words used were ovarian stimulation, in vitro fertilization, recombinant luteinizing hormone, supplementation LH. The aim of this study was to review the available literature and to assess the benefits of using recombinant luteinizing hormone associated with recombinant follicle stimulating hormone in different populations who have undergone assisted reproduction procedures.

Citing Articles

Effect of Exogenous Luteinizing Hormone (LH) Supplementation on Clinical Pregnancy of Patients Receiving Long-Acting Gonadotropin-Releasing Hormone Agonist (GnRHa) Cycles: A Retrospective Cohort Study.

Huang C, Shi Q, Yan Y, Shen X, Shan H, Zhu Y Int J Womens Health. 2022; 14:1691-1700.

PMID: 36536609 PMC: 9759025. DOI: 10.2147/IJWH.S388726.


Pregnancy confirmed after controlled ovarian stimulation for infertility: A case report.

Jiang M, Wang C, Fei X, Lin Z Medicine (Baltimore). 2021; 100(37):e27140.

PMID: 34664838 PMC: 8447983. DOI: 10.1097/MD.0000000000027140.


[Effects of luteinizing hormone supplementation on outcomes of in vitro fertilization and embryo transfer in patients undergoing GnRH-agonist long protocol].

Deng Y, Yin M, Liang P, Chen Z, Sun L Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37(11):1501-1505.

PMID: 29180331 PMC: 6779645.